Implementing Regulation (EU) 2018/1882, as recently amended by Commission Implementing Regulation (EU) 2026/169 [Commission Implementing Regulation (EU) 2026/169 of 26 January 2026 amending the Annex to Implementing Regulation (EU) 2018/1882 concerning the categorisation of infection with bluetongue virus (serotypes 1-24) as a listed disease (OJ L, 2026/169, 27.1.2026, ELI: http://data.europa.eu/eli/reg_impl/2026/169/oj).] re-categorises infection with BTV as a category D+E disease. Such re-categorisation means that the rules for BTV optional eradication programmes and disease-free status laid down in Article 2, Article 12, Articles 37 to 45, Article 66, Article 70, Article 72, Article 81 of Delegated Regulation (EU) 2020/689 and Part II of Annex V thereto are no longer relevant, as they only apply to category C diseases. Therefore, those rules should be deleted from those provisions of Delegated Regulation (EU) 2020/689.
Recital 5, Regulation (EU) 2026/797
In forcesince 27 Mar 2026